We are live on ! Find out more
XGN icon

Exagen
XGN

36 hedge funds and large institutions have $97.7M invested in Exagen in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $55.5M → $97.7M (+$42.1M)

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

33% more funds holding

Funds holding: 27 → 36 (+9)

0.84% more ownership

Funds ownership: 29.77% → 30.61% (+0.84%)

Holders
36
Holders Change
+9
Holders Change %
+33.33%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
7
Reduced
5
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$3.81M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.74M
3
RI
RTW Investments
New York
+$3.69M
4
BlackRock
BlackRock
New York
+$2.17M
5
Calamos Advisors
Calamos Advisors
Illinois
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$4.82M
2
MIM
Monashee Investment Management
Massachusetts
-$1.78M
3
SCM
Sio Capital Management
New York
-$1.32M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.05M
5
Norges Bank
Norges Bank
Norway
-$697K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$27K +$19.2K +1,079 New
SO
27
STRS Ohio
Ohio
$22K +$16K +900 New
Legal & General Group
28
Legal & General Group
United Kingdom
$18K +$12.6K +710 New
Citigroup
29
Citigroup
New York
$17K +$11.8K +664 New
Bank of America
30
Bank of America
North Carolina
$13K +$9.13K +513 New
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$11K +$7.42K +417 New
TRCT
32
Tower Research Capital (TRC)
New York
$11K +$7.54K +424 New
Wells Fargo
33
Wells Fargo
California
$7K +$4.79K +269 New
AIP
34
Ameritas Investment Partners
Nebraska
$7K +$5.07K +285 New
PCM
35
Prelude Capital Management
New York
$5K +$3.56K +200 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$5K +$3.58K +201 New
BC
37
Broadfin Capital
New York
– -$4.82M -311,284 Closed
MIM
38
Monashee Investment Management
Massachusetts
– -$1.78M -115,000 Closed
SCM
39
Sio Capital Management
New York
– -$1.32M -85,000 Closed
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
– -$1.05M -67,771 Closed
Norges Bank
41
Norges Bank
Norway
– -$697K -45,000 Closed
Millennium Management
42
Millennium Management
New York
– -$588K -37,964 Closed
Wellington Management Group
43
Wellington Management Group
Massachusetts
– -$495K -31,948 Closed
LCM
44
Laurion Capital Management
New York
– -$465K -30,000 Closed
Teacher Retirement System of Texas
45
Teacher Retirement System of Texas
Texas
– -$310K -20,000 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$279K -18,000 Closed
DIM
47
DC Investments Management
Virginia
– -$221K -14,244 Closed
MWNA
48
Marshall Wace North America
New York
– -$172K -11,100 Closed
CCA
49
Catalyst Capital Advisors
New York
– -$5K -329 Closed
FIA
50
FNY Investment Advisers
New York
– -$3K -200 Closed
1
2

XGN Hedge Fund Activity: Q4 2019 in Review

36 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2019, worth a combined $97.7M — up 76% from $55.5M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new XGN positions and 14 closed out — a net gain of 9 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $3.81M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.82M sold.

  • 36 institutional investors held Exagen (XGN) as of Q4 2019, up from 27 in Q3 2019.
  • Funds reported $97.7M of Exagen stock for Q4 2019, up 76% quarter-over-quarter.
  • 23 funds opened new Exagen positions in Q4 2019 and 14 closed out, a net change of +9 holders.
  • The largest Exagen buyer in Q4 2019 was Farallon Capital Management, an estimated $3.81M added.
  • The largest Exagen seller in Q4 2019 was Broadfin Capital, an estimated $4.82M sold.

Based on aggregated 13F filings for Q4 2019.